Trial NCT03912831

View at ClinicalTrials.gov 
Org. Study IDs: KT-US-478-0401

Last trial update was posted on 2023-12-26

MeSH Interventions

Cyclophosphamide Fludarabine Interleukin-2

MeSH Conditions


Other Conditions

Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer

Stopping Reasons

Development program terminated

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID